Abstract
The bacterial expression of human progastrin6–80 has been reported previously [Baldwin, G.S. et al. (2001) J. Biol. Chem. 276: 7791-7796]. The aims of the present study were to prepare full-length recombinant human progastrin1–80 and to compare its biological activity with that of progastrin6–80 in vitro, to determine whether or not the N-terminal five amino acids contributed to activity. A fusion protein of glutathione-S-transferase and human progastrin1–80 was expressed in Escherichia coli, collected on glutathione-agarose beads, and cleaved with enterokinase. Progastrin1–80 was purified by reversed-phase and anion exchange HPLC and characterized by radioimmunoassay, amino acid sequencing, and mass spectrometry. No differences were detected in the extent of stimulation by progastrin1–80 and progastrin6–80 in proliferation and migration assays with the mouse gastric cell line IMGE-5. We conclude that residues 1–5 of progastrin1–80 are not essential for biological activity.
Similar content being viewed by others
REFERENCES
Baldwin, G. S., and Shulkes, A. (1998). Gut 42: 581-584.
Baldwin, G. S., Hollande, F., Yang, Z., Karelina, Y., Paterson, A., Strang, R., et al. (2001). J. Biol. Chem. 276: 7791-7796.
Boel, E., Vuust, J., Norris, F., Norris, K., Wind, A., Rehfeld, J. F., et al. (1983). Proc. Natl. Acad. Sci. USA 80: 2866-2869.
Ciccotosto, G. D., McLeish, A., Hardy, K. J., and Shulkes, A. (1995). Gastroenterology 109: 1142-1153.
Collins-Racie, L. A., McColgan, J. M., Grant, K. L., DiBlasio-Smith, E. A., McCoy, J. M., and LaVallie, E. R. (1995). Biotechnology 13: 982-987.
Dockray, G. J., Varro, A., and Dimaline, R. (1996). Physiol. Rev. 76: 767-798.
Frangioni, J. V., and Neel, B. G. (1993). Anal. Biochem. 210: 179-187.
Gallagher, S. R. (1988) In: Coligan, J. E., Dunn, B. M., Ploegh, H. L., Speicher, D. W., and Wingfield, P. T. (eds.), Current Protocols in Protein Science. pp 10.1.11-10.1.12. John Wiley & Sons, New York.
Hollande, F., Blanc, E. M., Bali, J. P., Whitehead, R. H., Pelegrin, A., Baldwin, G. S., et al. (2001). Am. J. Physiol. 280: G910-G921.
Hollande, F., Choquet, A., Blanc, E. M., Lee, D. J., Bali, J. P., and Baldwin, G. S. (2001). J. Biol. Chem. 276: 40402-40410.
Hollande, F., Imdahl, A., Mantamadiotis, T., Ciccotosto, G. D., Shulkes, A., and Baldwin, G. S. (1997). Gastroenterology 113: 1576-1588.
Moore, C., Jie, R., Shulkes, A., and Baldwin, G. S. (1997). DNA Seq. 8: 39-44.
Rehfeld, J. F., and Johnsen, A. H. (1994). Eur. J. Biochem. 223: 765-773.
Seva, C., Dickinson, C. J., and Yamada, T. (1994). Science 265: 410-412.
Singh, P., Owlia, A., Varro, A., Dai, B., Rajaraman, S., and Wood, T. (1996). Cancer Res. 56: 4111-4115.
Singh, P., Velasco, M., Given, R., Varro, A., and Wang, T. C. (2000a). Gastroenterology 119: 162-171.
Singh, P., Velasco, M., Given, R., Wargovich, M., Varro, A., and Wang, T. C. (2000b). Am. J. Physiol. 278: G390-G399.
Smith, D. B., and Johnson, K. S. (1988). Gene 67: 31-40.
Wang, T. C., Koh, T. J., Varro, A., Cahill, R. J., Dangler, C. A., Fox, J. G., et al. (1996). J. Clin. Invest. 98: 1918-1929.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McQueen, K., Kovac, S., Ho, PK. et al. Preparation of Biologically Active Recombinant Human Progastrin1–80. J Protein Chem 21, 465–471 (2002). https://doi.org/10.1023/A:1021399003934
Published:
Issue Date:
DOI: https://doi.org/10.1023/A:1021399003934